Issue 6/2002
Content (7 Articles)
Original Article
Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines
Connie L. Sivinski, Karl G. Kohlgraf, Michelle L. VanLith, Keita Morikane, Richard M. Tempero, Michael A. Hollingsworth
Review
Immature myeloid cells and cancer-associated immune suppression
Sergei Kusmartsev, Dmitry I. Gabrilovich
Original Article
Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment
Hsin-Wei Chen, Hsing-I Huang, Yi-Ping Lee, Li-Li Chen, Hsiung-Kun Liu, Mei-Lien Cheng, Jy-Ping Tsai, Mi-Hua Tao, Chou-Chik Ting
Original Article
Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination
Joanna Galea-Lauri, David Darling, Ghulam Mufti, Phillip Harrison, Farzin Farzaneh
Original Article
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses
David Berd, Takami Sato, Michael J. Mastrangelo
Original Article
Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor
Xiang-Yang Wang, Ying Li, Masoud H. Manjili, Elizabeth A. Repasky, Drew M. Pardoll, John R. Subjeck
Letter to the Editors
Immunogenicity of WT-1 peptides
Ashley Knights, Ludmila Müller, Graham Pawelec